Literature DB >> 20882608

Predicting survival in glioblastomas using diffusion tensor imaging metrics.

Sona Saksena1, Rajan Jain, Jayant Narang, Lisa Scarpace, Lonni R Schultz, Norman L Lehman, David Hearshen, Suresh C Patel, Tom Mikkelsen.   

Abstract

PURPOSE: To retrospectively correlate various diffusion tensor imaging (DTI) metrics in patients with glioblastoma multiforme (GBM) with patient survival analysis and also degree of tumor proliferation index determined histologically.
MATERIALS AND METHODS: Thirty-four patients with histologically confirmed treatment naive GBMs underwent DTI on a 3.0 Tesla (T) scanner. Region-of-interest was placed on the whole lesion including the enhancing as well as nonenhancing component of the lesion to determine the various DTI metrics. Kaplan-Meier estimates and Cox proportional hazards regression methods were used to assess the relationship of DTI metrics (minimum and mean values) and Ki-67 with progression free survival (PFS). To study the relationship between DTI metrics and Ki-67, Pearson's correlation coefficient was computed.
RESULTS: Univariate analysis showed that patients with fractional anisotropy (FA)(mean) ≤ 0.2, apparent diffusion coefficient (ADC)(min) ≤ 0.6, planar anisotropy (CP)(min) ≤ 0.002, spherical anisotropy (CS)(mean) > 0.68 and Ki-67 > 0.3 had lower PFS rate. The multivariate analysis demonstrated that only CP(min) was the best predictor of survival in these patients, after adjusting for age, Karnofsky performance scale and extent of resection. No significant correlation between DTI metrics and Ki-67 were observed.
CONCLUSION: DTI metrics can be used as a sensitive and early indicator for PFS in patients with glioblastomas. This could be useful for treatment planning as high-grade gliomas with lower ADC(min), FA(mean), CP(min), and higher CS(mean) values may be treated more aggressively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882608     DOI: 10.1002/jmri.22304

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  19 in total

Review 1.  MR-guided radiation therapy: transformative technology and its role in the central nervous system.

Authors:  Yue Cao; Chia-Lin Tseng; James M Balter; Feifei Teng; Hemant A Parmar; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.

Authors:  Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

3.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.

Authors:  Myriam M Chaumeil; Tomoko Ozawa; IlWoo Park; Kristen Scott; C David James; Sarah J Nelson; Sabrina M Ronen
Journal:  Neuroimage       Date:  2011-07-23       Impact factor: 6.556

Review 4.  Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.

Authors:  Nathan S White; Carrie McDonald; Carrie R McDonald; Niky Farid; Josh Kuperman; David Karow; Natalie M Schenker-Ahmed; Hauke Bartsch; Rebecca Rakow-Penner; Dominic Holland; Ahmed Shabaik; Atle Bjørnerud; Tuva Hope; Jona Hattangadi-Gluth; Michael Liss; J Kellogg Parsons; Clark C Chen; Steve Raman; Daniel Margolis; Robert E Reiter; Leonard Marks; Santosh Kesari; Arno J Mundt; Christopher J Kane; Christopher J Kaine; Bob S Carter; William G Bradley; Anders M Dale
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

5.  Morphologic MRI features, diffusion tensor imaging and radiation dosimetric analysis to differentiate pseudo-progression from early tumor progression.

Authors:  Ajay Agarwal; Sanath Kumar; Jayant Narang; Lonni Schultz; Tom Mikkelsen; Sumei Wang; Sarmad Siddiqui; Harish Poptani; Rajan Jain
Journal:  J Neurooncol       Date:  2013-02-18       Impact factor: 4.130

6.  Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.

Authors:  Andrew Elson; Joseph Bovi; Malika Siker; Chris Schultz; Eric Paulson
Journal:  J Neurooncol       Date:  2015-02-21       Impact factor: 4.130

7.  Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.

Authors:  Yi Cui; Shangjie Ren; Khin Khin Tha; Jia Wu; Hiroki Shirato; Ruijiang Li
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

8.  Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases.

Authors:  W L Tan; W Y Huang; B Yin; J Xiong; J S Wu; D Y Geng
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-20       Impact factor: 3.825

9.  Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages.

Authors:  Dong Nie; Junfeng Lu; Han Zhang; Ehsan Adeli; Jun Wang; Zhengda Yu; LuYan Liu; Qian Wang; Jinsong Wu; Dinggang Shen
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

10.  Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).

Authors:  Lei Qin; Angie Li; Jinrong Qu; Katherine Reinshagen; Xiang Li; Su-Chun Cheng; Annie Bryant; Geoffrey S Young
Journal:  J Neurooncol       Date:  2018-01-30       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.